Ovarian hyperstimulation with exogenous pulsatile gonadotropin releasing hormone therapy.
Two cases are reported of women with hypothalamic amenorrhea who had sonographic and biochemical evidence of ovarian hyperstimulation during the first cycle of exogenous pulsatile gonadotropin releasing hormone (GnRH) therapy. In one case, it was demonstrated that, with early detection, decrease in the dosage of GnRH may stabilize the condition and prevent further progression of the hyperstimulation. Therefore, the authors suggest that sonographic monitoring should be performed at least in the initial ovulatory cycle so that adjustment of the dosage of GnRH can be made with early detection of hyperstimulation.
D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D010053:Ovary / Q000187:drug effects*; D010062:Ovulation Induction / Q000379:methods; D010906:Pituitary Hormone-Releasing Hormones / Q000009:adverse effects*; D014463:Ultrasonography
D010906:Pituitary Hormone-Releasing Hormones